AI tool to assess cancer risk and guide care
Part of Cancer, Digestive system, Lungs & breathing clinical trials.
This study tests an artificial intelligence (AI) system that uses your health information and medical images to better judge cancer risk and support diagnosis and treatment decisions. It may help doctors make more consistent assessments by combining clinical records, imaging, and other lab-style data.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are being checked for lung cancer, stomach cancer, or colorectal cancer (or you are a healthy person being evaluated).
- You can sign informed consent to join the study.
- You have detailed electronic medical records and stored results (including images and pathology reports).
- You have usable medical images, with quality high enough for the AI to outline the area of concern accurately.
- Your key medical data (clinical/pathology information) are complete and you are not missing major records.
- You can be followed up through the study (not lost to follow-up).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study is testing a new way to use medical images, records, and other information to better assess cancer risk and guide treatment. It may be a good fit if you have a suspicious spot in your lungs, stomach, or colon, or if you are healthy and want to help with early cancer detection research.
This study tests how well an AI tool can predict lung cancer risk, based on your health information. It looks at how patients feel about this approach to screening, with the goal of making screening more personal and effective.
This trial tests an artificial intelligence platform that helps doctors predict if lymph nodes in the chest contain cancer during a routine ultrasound procedure. It aims to make staging more accurate for people with suspected or confirmed non-small cell lung cancer.
This trial tests whether using AI to help radiologists read lung CT scans can find cancer earlier and lower healthcare costs. You may qualify if you are at risk for lung cancer and have not been screened recently.
This trial tests whether an artificial intelligence (AI) tool can help doctors plan radiation therapy more precisely for breast cancer. It aims to make treatment safer and more effective by using AI to outline the area to be treated.
This trial uses artificial intelligence to improve low-dose CT scans for early lung cancer detection. If you are at higher risk due to smoking or family history, or just want a routine check, you may be able to join.
Hear when a new Deep Learning trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.